This compound is primarily utilized in the field of biomedical research, particularly in targeted protein degradation studies. It serves as a key component in the development of PROTACs (Proteolysis Targeting Chimeras), which are innovative molecules designed to selectively degrade disease-causing proteins. By facilitating the breakdown of specific proteins, it aids in understanding cellular processes and identifying potential therapeutic targets for diseases such as cancer and neurodegenerative disorders. Its application extends to drug discovery, where it helps in validating protein function and exploring novel treatment strategies.